Global: Poor states should start campaign on patent rights

Pharmaceutical industries in emerging markets are shifting their focus away from poor to developed countries, which will affect access to cheap generic medicines. Poor states should tackle this development by capitalising on the international trade exemptions they still enjoy regarding medicines as 'intellectual property'. These comments come from a new report by the United Nations Conference on Trade and Development (UNCTAD), titled 'Investment in Pharmaceutical Production in the Least Developed Countries', or LDCs.